跳至主要内容
临床试验/NCT02615301
NCT02615301已完成不适用

Intake of Dietary Vitamin D and K From Tailor-made Atlantic Salmon and Bone Health - A Randomized Intervention Study

National Institute of Nutrition and Seafood Research, Norway2 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2009年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
122
试验地点
2
主要终点
Osteocalcin

研究概览

简要总结

The aims of this study were to investigate how intake of tailor-made salmon affected bone biomarkers, nutritional status, as well as body composition and bone mineral density. The 122 healthy postmenopausal women included in this 12 weeks intervention study were randomized into four groups: three salmon groups (with three different vitamin D3/vitamin K1 combinations) and one tablet group (vitamin D and Calcium).

详细描述

Suboptimal vitamin D status is common among humans, and might have a negative impact on bone health. Fatty fish, including Atlantic salmon, is an important dietary vitamin D source. However, due to a considerable change in fish feed composition, the contribution of vitamin D from salmon fillet has been reduced. The aims were to investigate how intake of tailor-made salmon affected bone biomarkers, nutritional status (vitamin D, omega-3), as well as body composition and bone mineral density (BMD). The 122 healthy postmenopausal women (median 55 years) included in this 12 weeks intervention study were randomized into four groups: three salmon groups (150 grams/two times/week) and one tablet group (800IU vitamin D and 1000 mg Calcium/day). The salmon groups also received calcium supplements (1000 mg/d). The salmon had three different vitamin D3/vitamin K1 combinations: high D3 + high K1, low D3 + high K1, or high D3 + low K1.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
50 Years 至 64 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Postmenopausal women
  • Caucasian ethnicity
  • Age range 50-65 years
  • Having postmenopausal age of at least one year

排除标准

  • Osteoporotic fractures
  • Medical treatment for osteoporosis
  • Warfarin treatment
  • Creatinine above or below normal range
  • Hypervitaminosis D
  • Malabsorption syndrome
  • Inflammatory bowel disease
  • Inflammatory rheumatic diseases
  • Women who had planned to go away on holiday during the intervention could not participate

结局指标

主要结局

Osteocalcin

时间窗: 3 months

Serum (ng/ml)

Carboxylated osteocalcine (GLA)

时间窗: 3 months

Serum (ng/ml)

N-telopeptides/creatinine

时间窗: 3 months

Urinary (mmol/l)

GLU/GLA-ratio

时间窗: 3 months

Ratio of undercarboxylated osteocalcin and carboxylated osteocalcine

Deoxypyridinoline/creatinine

时间窗: 3 months

Urinary (mmol/l)

Undercarboxylated osteocalcin (GLU)

时间窗: 3 months

Serum (ng/ml)

Bone-specific alkaline phosphatase

时间窗: 3 months

Serum (µg/l)

次要结局

  • 25-hyroxyvitamin D(3 months)
  • Bone mineral density(3 months)
  • Body composition(3 months)
  • Docosahexaenoic acids(3 months)
  • Omega-3 index(3 months)
  • Eicosapentaenoic acids(3 months)

研究者

发起方
National Institute of Nutrition and Seafood Research, Norway
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Jannike Øyen

Jannike Øyen, PhD

National Institute of Nutrition and Seafood Research, Norway

研究点 (2)

Loading locations...

相似试验